Core Points - The document outlines the procedures and principles for the resignation of directors at Jilin Xidian Pharmaceutical Technology Development Co., Ltd, ensuring compliance with laws and regulations [1][2][3] - The company emphasizes the importance of maintaining governance stability and protecting shareholder rights during the director resignation process [1][2] Group 1: Resignation Procedures - Directors who fail to attend board meetings twice consecutively without delegation are considered unable to fulfill their duties, leading to a recommendation for their replacement [2] - Directors can resign before their term ends by submitting a written resignation report, which becomes effective upon receipt by the company [2] - The company must disclose the resignation details within two trading days and complete the re-election of directors within sixty days to ensure compliance with legal requirements [2][3] Group 2: Responsibilities and Obligations of Resigning Directors - Resigning directors must complete all handover procedures within five days of their official departure, including the transfer of relevant documents and responsibilities [4] - Directors are required to continue fulfilling any public commitments made during their tenure, even after resignation [4][5] - The confidentiality obligations regarding company trade secrets remain in effect after a director's departure until such information becomes public [5] Group 3: Shareholding Management - Resigning directors are prohibited from transferring their shares within six months of leaving the company [6] - Any changes in shareholding must comply with previously made commitments regarding shareholding proportions and durations [6][6] - The company secretary is responsible for monitoring the shareholding changes of resigning directors and reporting to regulatory authorities if necessary [6]
西点药业: 董事离职管理制度